Literature DB >> 22727836

Performance of rapid immunochromatographic assay in the diagnosis of Trichomoniasis vaginalis.

Mamdouh M Hegazy1, Nora L El-Tantawy, Mohamed M Soliman, Ehaab S El-Sadeek, Hassan S El-Nagar.   

Abstract

Trichomonas vaginalis accounts for nearly half of all curable sexually transmitted diseases worldwide with serious health consequences. Effort to increase the sensitivity of its diagnosis is critical to both control measures and epidemiologic studies. This study was conducted to evaluate the OSOM® Trichomonas Rapid Test (Sekisui Diagnostics, Framingham, MA, USA), a qualitative antigen-detection immunochromatographic (IC) assay in the diagnosis of vaginal trichomoniasis comparable to the conventional methods. The study enrolled 258 females aged 18-50 years classified into symptomatic (185) and asymptomatic (73) groups. Vaginal swab specimens were obtained for wet mount, stained preparation (Giemsa, acridine-orange), culture (InPouch TV™, modified Diamond's), and for rapid OSOM testing. Trichomonas vaginalis was detected in 67, 66, 71, 99, 96, and 97 using wet mount, acridine-orange stain, Giemsa stain, modified Diamond's, InPouch media, and OSOM test, respectively. In comparison to a composite reference standard (CRS) of wet mount microscopy and culture, OSOM test reported 97.98%, 99.37%, 98.98%, 98.75%, and 98.84% for sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy, respectively. The OSOM test proved to be a simple and objective test. This rapid point-of-care-test will contribute significantly in the diagnosis of vaginal trichomoniasis and will increase the understanding of its still vague epidemiology.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22727836     DOI: 10.1016/j.diagmicrobio.2012.05.003

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  11 in total

1.  The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population.

Authors:  Aida A Abdel-Magied; El-Said I El-Kholya; Salwa M Abou El-Khair; Eman S Abdelmegeed; Marwa M Hamoudaa; Sara A Mohamed; Nora Labeeb El-Tantawy
Journal:  Parasitol Res       Date:  2017-09-27       Impact factor: 2.289

Review 2.  Modern diagnosis of Trichomonas vaginalis infection.

Authors:  Marcia M Hobbs; Arlene C Seña
Journal:  Sex Transm Infect       Date:  2013-04-30       Impact factor: 3.519

3.  Identification, characterization, and synthesis of peptide epitopes and a recombinant six-epitope protein for Trichomonas vaginalis serodiagnosis.

Authors:  J F Alderete; Calvin J Neace
Journal:  Immunotargets Ther       Date:  2013-08-12

4.  Impact of deploying multiple point-of-care tests with a 'sample first' approach on a sexual health clinical care pathway. A service evaluation.

Authors:  Emma M Harding-Esch; Achyuta V Nori; Aseel Hegazi; Marcus J Pond; Olanike Okolo; Anthony Nardone; Catherine M Lowndes; Phillip Hay; S Tariq Sadiq
Journal:  Sex Transm Infect       Date:  2017-02-03       Impact factor: 3.519

Review 5.  Point-of-Care Sexually Transmitted Infection Diagnostics: Proceedings of the STAR Sexually Transmitted Infection-Clinical Trial Group Programmatic Meeting.

Authors:  Anthony D Cristillo; Claire C Bristow; Rosanna Peeling; Barbara Van Der Pol; Sasha Herbst de Cortina; Ivan K Dimov; Nitika Pant Pai; Dong Jin Shin; Ricky Y T Chiu; Catherine Klapperich; Purnima Madhivanan; Sheldon R Morris; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2017-04       Impact factor: 2.830

6.  Beyond syndromic management: Opportunities for diagnosis-based treatment of sexually transmitted infections in low- and middle-income countries.

Authors:  Nigel J Garrett; Farzana Osman; Bhavna Maharaj; Nivashnee Naicker; Andrew Gibbs; Emily Norman; Natasha Samsunder; Hope Ngobese; Nireshni Mitchev; Ravesh Singh; Salim S Abdool Karim; Ayesha B M Kharsany; Koleka Mlisana; Anne Rompalo; Adrian Mindel
Journal:  PLoS One       Date:  2018-04-24       Impact factor: 3.240

7.  Diagnostic accuracy of the Xpert CT/NG and OSOM Trichomonas Rapid assays for point-of-care STI testing among young women in South Africa: a cross-sectional study.

Authors:  Nigel Garrett; Nireshni Mitchev; Farzana Osman; Jessica Naidoo; Jienchi Dorward; Ravesh Singh; Hope Ngobese; Anne Rompalo; Koleka Mlisana; Adrian Mindel
Journal:  BMJ Open       Date:  2019-02-19       Impact factor: 2.692

Review 8.  A Systematic Review of Point of Care Testing for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis.

Authors:  Sasha Herbst de Cortina; Claire C Bristow; Dvora Joseph Davey; Jeffrey D Klausner
Journal:  Infect Dis Obstet Gynecol       Date:  2016-05-26

9.  MALDI-TOF mass spectrometry as a potential tool for Trichomonas vaginalis identification.

Authors:  Adriana Calderaro; Maddalena Piergianni; Sara Montecchini; Mirko Buttrini; Giovanna Piccolo; Sabina Rossi; Maria Cristina Arcangeletti; Maria Cristina Medici; Carlo Chezzi; Flora De Conto
Journal:  BMC Infect Dis       Date:  2016-06-10       Impact factor: 3.090

Review 10.  Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis infection.

Authors:  Olivia T Van Gerwen; Christina A Muzny
Journal:  F1000Res       Date:  2019-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.